Breakthrough antibody therapy targets Alzheimer’s risk gene, offers hope for effective treatment Post author: Post published:October 6, 2023 Post category:uncategorized Researchers introduced and characterized a novel platform based on monoclonal antibodies (mAbs). You Might Also Like UTHealth Houston study to examine how eviction protection during the pandemic affects mental health October 18, 2023 What links dust mites, shellfish, and insect food allergies? April 23, 2025 New consortium tackles genetic origins of neurodevelopmental and psychiatric disorders September 12, 2024
UTHealth Houston study to examine how eviction protection during the pandemic affects mental health October 18, 2023
New consortium tackles genetic origins of neurodevelopmental and psychiatric disorders September 12, 2024